Best Radiotherapy Doctors Worldwide — TOP 152

Prof. Atalar specializes in Stereotactic Radiosurgery (SRS) and MR-Guided Adaptive SRS, trained at Stanford University. With 72 peer-reviewed publications, she brings cutting-edge research to clinical practice.

• Completed fellowship at Stanford University in Stereotactic Radios deposition
• Board-certified radiation oncologist with Turkiye certification
• Holds honorary fellowship from American College of Radiology
• President of Turkish Society for Radiation Oncology (2025-2027)
• Published extensively with a focus on CNS, thoracic, and gastrointestinal tumors

Professor Doctor Sefik Igdem specializes in advanced radiotherapy techniques at Gayrettepe Florence Nightingale Hospital.

• Over 30 years of experience in radiation oncology
• Expert in conformal treatments and Truebeam Stx Technology
• Specializes in head and neck cancers and prostate cancer
• Professor at T.R Demiroğlu Bilim University

Dr. Li Yanwen is an early leader in functional neurosurgery in China. He is a founder of neurosurgical navigation in the country. He is a Visiting Professor at the University of Turin. His awards include the First Prize of the Shenzhen Science and Technology Progress Award and the Third Prize of the Guangdong Provincial Science and Technology Progress Award.

He specializes in stereotactic and functional neurosurgery. He has over 20 years of experience and has completed more than 10,000 surgical localization procedures for Parkinson’s disease, cerebral palsy, and epilepsy. He is skilled in stereotactic and navigation techniques. His focus includes precision treatment for hard-to-treat cerebral hemorrhage and traumatic brain injury, post-stroke paralysis, Parkinson’s disease, Alzheimer’s disease, and spinal cord injury. He also performs targeted surgery for autism. He studies stem-cell therapies for neurological and autoimmune diseases.

Dr. Shira Felder leads the Gynecologic Oncology Service at Sheba Medical Center. She is a senior radiation oncologist specializing in gynecologic and urologic cancers. She trained at the Princess Margaret Cancer Centre in Toronto. Dr. Felder focuses on delivering targeted radiation while preserving her patients' quality of life.

• Uses precision techniques including VMAT, IMRT, SBRT, and brachytherapy.
• Treats cervical, uterine, ovarian, and prostate cancers.
• Maintains membership in the European Society for Radiotherapy & Oncology.
• Works at Sheba Medical Center, ranked 7th globally by Newsweek.
• Conducts research on brachytherapy safety and cervical cancer survival.

Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.

• Authored over 40 research publications focusing on tumor biology and immunology.
• Former Head of Internal Diseases at Istanbul Okan University Faculty of Medicine.
• Held leadership roles in medical oncology at GATA Haydarpasa Training Hospital.
• Member of the Turkish Medical Oncology Association and European Head and Neck Society.

Dr. Ilker Tinay is an urological oncologist at Anadolu Medical Center. He sits on the Executive Board of the Association of Urooncology. Dr. Tinay specializes in minimally invasive surgery and neo-bladder reconstruction. He works at Anadolu, a Top 10 global hospital according to MTQUA. The center is also affiliated with Johns Hopkins Medicine.

• Member of the American College of Surgeons and European Association of Urology.
• Secretary of the Bladder Tumours Research Group.
• Winner of the Urooncology Association Scientific Research Award.
• Performs complex procedures including robotic da Vinci prostatectomy and nephrectomy.

Dr. Serdar Turhal is a highly experienced oncologist specializing in medical oncology and chemotherapy for breast cancer at Anadolu Medical Center. He is a member of many international oncology associations and has authored numerous articles in international publications. He specializes in prognostic factors and the therapy of malignant gastrointestinal neoplasms. To receive a consultation from Dr. Turhal, please submit a request on Bookimed.

Dr. Cuneyt Turkmen is a nuclear medicine specialist at Memorial Şişli Hospital in Istanbul. He has published over 80 scientific papers on oncology and imaging. Dr. Turkmen completed a professional fellowship at Sahlgrenska University Hospital in Sweden. He focuses on targeted radionuclide therapy for liver, prostate, and thyroid cancers.

• Performs radioembolization and Lutetium-177 therapy for advanced cancer cases.
• Expertise in Actinium-225 radiation and Amyloid PET scans.
• Member of the European Association of Nuclear Medicine.
• Works at a JCI-accredited hospital, the first in Turkey to reach this standard.

Associate Professor Muhammet Derda Ozer specializes in ophthalmology with a focus on ocular oncology and advanced treatments.

• Trained at Wills Eye Institute's Ocular Oncology Department
• Published multiple studies on retinal and choroidal conditions
• Active member of the Turkish Ophthalmological Association
• Holds International Council of Ophthalmology certifications

Leading expert in lung cancer radiotherapy, combining genomics with precision oncology at Sourasky Medical Center.

• PI for clinical trials on pembrolizumab and platinum-based chemotherapy in NSCLC
• Moderator of the Israeli Lung Cancer Society's Molecular Tumor Board
• Expert in liquid biopsies and comprehensive genomic profiling
• Outstanding teacher at Tel-Aviv University's Faculty of Medicine
• Member of ESMO and IASLC

Professor Raimon Miralbell is a world-renowned expert in radiation oncology, specializing in prostate cancer treatment with advanced radiotherapy techniques.

• Head of the Radiation Oncology Department at Centro Médico Teknon since 1999
• Trained at prestigious institutions including Harvard Cyclotron Laboratory and Royal Marsden Hospital
• Recipient of the Varian Award for Radiation Oncology
• Author of over 100 scientific publications on radiotherapy techniques
• Cooperates with CERN on advanced radiation research

Dr. Buhl is a leading neurosurgeon with a focus on brain and spinal cord surgeries, including advanced neuro-oncology cases.

• Specializes in minimally invasive and endoscopic neurosurgery
• Published 47 scientific papers on neuropathology
• Cofounded a research fund for brain tumor studies
• Recognized expert in treating herniated discs and spinal fractures

Dr. Luan Tianyan, MD, is Head of Oncology. He was recruited to Hainan Province as a high-level talent. He is a visiting scholar at the Dana-Farber Cancer Institute (USA). He is also Director of the Clinical Research Office at Bozheng Hengda International Hospital. He serves on the standing committees of the Clinical Research Management Committee (Southern Oncology Clinical Research Association), the Immunotherapy Committee (Hainan Provincial Anti-Cancer Association), and the Hainan Province Drug Research Committee.

He has more than 20 years of oncology practice. He provides individualized, comprehensive care for gastrointestinal tumors, lung cancer, and breast cancer. He focuses on pain management, palliative care, and psychological support in advanced cancer. He also works on the clinical use and study of tumor immunotherapy, including personalized mRNA vaccines and CAR-T therapy. He develops and applies proprietary drugs and related technologies.

Head of the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center – specializes in sarcoma treatments combining radiotherapy with advanced techniques.

• Over 41 years of experience in oncology with a focus on sarcoma
• Fellowship-trained at Institut Gustave Roussy in France – a leading sarcoma center
• Member of ESMO Sarcoma Faculty and active in international oncology research
• Author of numerous publications on sarcoma and radiotherapy

Dr. Pelles Sharon specializes in radiotherapy and has made notable contributions to clinical research, including a study on patients' attitudes towards clinical trials.

• Highly respected oncologist with extensive experience
• Offers a wide range of cancer treatments including SIRT therapy and HIPEC
• Based at Sourasky Medical Center (Ichilov)
• Conducted research on clinical trial participation

Dr. Ronit El Hasid heads Pediatric Oncohematology at Dana Dwek Children’s Hospital, with 300+ bone marrow transplants performed.

• Specializes in pediatric bone marrow and umbilical cord blood transplantation
• 50+ publications and 40 conference reports in hematooncology
• Fellow of City of Hope Hospital in Los Angeles
• Member of American Association for Hematology

Dr. Amos Toren is a pediatric hemato-oncologist at Sheba Medical Center. He served as Director of the Pediatric Hemato-Oncology and Bone Marrow Transplant Division. Dr. Toren holds a PhD in Human Genetics. He specializes in CAR T-cell therapy and bone marrow transplantation for children. Forbes Israel has recognized his expertise in hematology.

• Served as the Head of the Hematology Division at Tel Aviv University.
• Treats complex cases of leukemia, lymphoma, and rare pediatric cancers.
• Member of the American Society of Hematology and European Group for Blood and Marrow Transplantation.
• Collaborates on research with the NIH and St. Jude Children’s Research Hospital.

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. Ayshe Okumush is a radiation oncologist at Private NeoLife Medical Center. She earned her MD from Karadeniz Technical University in 2003. She completed a residency in radiation oncology at Sisli Etfal Training and Research Hospital from 2006 to 2011.

She served as a specialist at Diyarbakir Uckuyular Training and Research Hospital from 2011 to 2013 and at Sisli Etfal from 2013 to 2016. She then worked at Yeni Yuzyil University Private Gaziosmanpasa Hospital from 2016 to 2026. She joined NeoLife in 2026.

Memberships: Turkish Society for Radiation Oncology (TROD) and the European Society for Radiotherapy and Oncology (ESTRO). Clinical focus: SRS, SRT, SBRT; VMAT, IMRT; radiotherapy for head and neck, lung, and brain tumors; SGRT, TBI, and 3D brachytherapy.